Literature DB >> 25331887

WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.

Mohammad Abu-Odeh1, Zaidoun Salah2, Christoph Herbel3, Thomas G Hofmann3, Rami I Aqeilan4.   

Abstract

Genomic instability is a hallmark of cancer. The WW domain-containing oxidoreductase (WWOX) is a tumor suppressor spanning the common chromosomal fragile site FRA16D. Here, we report a direct role of WWOX in DNA damage response (DDR) and DNA repair. We show that Wwox deficiency results in reduced activation of the ataxia telangiectasia-mutated (ATM) checkpoint kinase, inefficient induction and maintenance of γ-H2AX foci, and impaired DNA repair. Mechanistically, we show that, upon DNA damage, WWOX accumulates in the cell nucleus, where it interacts with ATM and enhances its activation. Nuclear accumulation of WWOX is regulated by its K63-linked ubiquitination at lysine residue 274, which is mediated by the E3 ubiquitin ligase ITCH. These findings identify a novel role for the tumor suppressor WWOX and show that loss of WWOX expression may drive genomic instability and provide an advantage for clonal expansion of neoplastic cells.

Entities:  

Keywords:  ITCH; WW domain-containing oxidoreductase; ataxia telangiectasia-mutated; common fragile sites; genomic instability

Mesh:

Substances:

Year:  2014        PMID: 25331887      PMCID: PMC4226089          DOI: 10.1073/pnas.1409252111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

Review 1.  ATM and ATR: networking cellular responses to DNA damage.

Authors:  Y Shiloh
Journal:  Curr Opin Genet Dev       Date:  2001-02       Impact factor: 5.578

2.  Wwox inactivation enhances mammary tumorigenesis.

Authors:  S K Abdeen; Z Salah; B Maly; Y Smith; R Tufail; M Abu-Odeh; N Zanesi; C M Croce; Z Nawaz; R I Aqeilan
Journal:  Oncogene       Date:  2011-04-18       Impact factor: 9.867

Review 3.  Studies of genomic copy number changes in human cancers reveal signatures of DNA replication stress.

Authors:  Aygül Dereli-Öz; Gwennaelle Versini; Thanos D Halazonetis
Journal:  Mol Oncol       Date:  2011-05-20       Impact factor: 6.603

4.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

5.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

Review 6.  FRA3B and other common fragile sites: the weakest links.

Authors:  K Huebner; C M Croce
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

7.  Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.

Authors:  Rami I Aqeilan; Yuri Pekarsky; Juan J Herrero; Alexey Palamarchuk; Jean Letofsky; Teresa Druck; Francesco Trapasso; Shuang-Yin Han; Gerry Melino; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.

Authors:  Zaidoun Salah; Gerry Melino; Rami I Aqeilan
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

10.  The landscape of somatic copy-number alteration across human cancers.

Authors:  Rameen Beroukhim; Craig H Mermel; Dale Porter; Guo Wei; Soumya Raychaudhuri; Jerry Donovan; Jordi Barretina; Jesse S Boehm; Jennifer Dobson; Mitsuyoshi Urashima; Kevin T Mc Henry; Reid M Pinchback; Azra H Ligon; Yoon-Jae Cho; Leila Haery; Heidi Greulich; Michael Reich; Wendy Winckler; Michael S Lawrence; Barbara A Weir; Kumiko E Tanaka; Derek Y Chiang; Adam J Bass; Alice Loo; Carter Hoffman; John Prensner; Ted Liefeld; Qing Gao; Derek Yecies; Sabina Signoretti; Elizabeth Maher; Frederic J Kaye; Hidefumi Sasaki; Joel E Tepper; Jonathan A Fletcher; Josep Tabernero; José Baselga; Ming-Sound Tsao; Francesca Demichelis; Mark A Rubin; Pasi A Janne; Mark J Daly; Carmelo Nucera; Ross L Levine; Benjamin L Ebert; Stacey Gabriel; Anil K Rustgi; Cristina R Antonescu; Marc Ladanyi; Anthony Letai; Levi A Garraway; Massimo Loda; David G Beer; Lawrence D True; Aikou Okamoto; Scott L Pomeroy; Samuel Singer; Todd R Golub; Eric S Lander; Gad Getz; William R Sellers; Matthew Meyerson
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

View more
  36 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

2.  Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Hiroshi Handa; Yoshiko Sasaki; Hikaru Hattori; Lobna Alkebsi; Tetsuhiro Kasamatsu; Takayuki Saitoh; Takeki Mitsui; Akihiko Yokohama; Norifumi Tsukamoto; Morio Matsumoto; Hirokazu Murakami
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

3.  HBXIP, a binding protein of HBx, regulates maintenance of the G2/M phase checkpoint induced by DNA damage and enhances sensitivity to doxorubicin-induced cytotoxicity.

Authors:  Hongrong Fei; Yunsheng Zhou; Ruotong Li; Mingfeng Yang; Jian Ma; Fengze Wang
Journal:  Cell Cycle       Date:  2017-01-19       Impact factor: 4.534

4.  Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.

Authors:  Morgan S Schrock; Jenna R Karras; Matthew J Guggenbiller; Teresa Druck; Bahadir Batar; Kay Huebner
Journal:  Adv Biol Regul       Date:  2016-09-26

Review 5.  Decoding the link between WWOX and p53 in aggressive breast cancer.

Authors:  Suhaib K Abdeen; Rami I Aqeilan
Journal:  Cell Cycle       Date:  2019-05-16       Impact factor: 4.534

6.  WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.

Authors:  Sara Del Mare; Hussam Husanie; Ortal Iancu; Mohammad Abu-Odeh; Konstantinos Evangelou; Francesca Lovat; Stefano Volinia; Jonathan Gordon; Gail Amir; Janet Stein; Gary S Stein; Carlo M Croce; Vassilis Gorgoulis; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2016-08-22       Impact factor: 12.701

Review 7.  WWOX, large common fragile site genes, and cancer.

Authors:  Ge Gao; David I Smith
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-16

Review 8.  The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability.

Authors:  Rami I Aqeilan; Muhannad Abu-Remaileh; Mohammad Abu-Odeh
Journal:  Cell Mol Life Sci       Date:  2014-09-23       Impact factor: 9.261

Review 9.  Pleiotropic Functions of Tumor Suppressor WWOX in Normal and Cancer Cells.

Authors:  Muhannad Abu-Remaileh; Emma Joy-Dodson; Ora Schueler-Furman; Rami I Aqeilan
Journal:  J Biol Chem       Date:  2015-10-23       Impact factor: 5.157

Review 10.  Molecular Functions of WWOX Potentially Involved in Cancer Development.

Authors:  Karim Taouis; Keltouma Driouch; Rosette Lidereau; François Lallemand
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.